IP Library Granted Patent US 10,370,700
Granted Patent B2
US 10,370,700 · App. 16/132,955 · Granted Aug 6, 2019

Detection of targeted sequence regions

Inventors: Anthony P. Shuber (Wakefield, MA); William Glover (Wakefield, MA); Thomas C. Meyers (Boston, MA)
Assignee: GENETICS RESEARCH, LLC
C12Q1/6806C12Q1/701
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,370,700
App. No.
16/132,955
Granted
Aug 6, 2019
Kind
B2
Abstract

Provided herein are methods of detecting nucleic acids. The nucleic acid of interest may be detected by using Cas endonuclease to degrade substantially all nucleic acid in a sample except for the nucleic acid of interest, leaving the nucleic acid of interest isolated and amenable to detection. In related methods, Cas endonuclease complexes are used to protect the nucleic acid of interest while unprotected nucleic acid is digested, e.g., by exonuclease, after which the isolated nucleic acid of interest is detected.

Claims (22)

1. A method of detecting a nucleic acid, the method comprising:

protecting, in a population of nucleic acids in a sample from an organism, first and second ends of a target nucleic acid using a first Cas endonuclease and a second Cas endonuclease, wherein the target nucleic acid is endogenous to the organism;

digesting unprotected nucleic acids with exonuclease; and

detecting the protected target nucleic acid.

2. The method of claim 1 , wherein:

the first Cas endonuclease and the second Cas endonuclease complex are different,

substantially all of the unprotected nucleic acids are degraded, and

the target nucleic acid is from a genome of the organism.

3. The method of claim 1 , wherein the organism is a human.

4. The method of claim 1 , wherein the first Cas endonuclease comprises a first Cas9 protein complexed with a first guide RNA, and the second Cas endonuclease comprises a second Cas9 protein complexed with a second guide RNA.

5. The method of claim 4 , wherein at least one of the first Cas9 complex and the second Cas9 complex comprises a catalytically inactive Cas9 protein.

6. The method of claim 1 , wherein the population of nucleic acids is isolated from the organism and the target nucleic acid comprises a sequence from a genome of the organism.

7. The method of claim 1 , wherein: the population of nucleic acids is isolated from an organism and the target nucleic acid is from a mitochondrial genome of the organism.

8. The method of claim 1 , wherein the detecting step comprises one selected from the group consisting of hybridization, spectrophotometry, sequencing, electrophoresis, amplification, fluorescence detection, and chromatography.

9. The method of claim 1 , wherein the detecting step comprises sequencing.

10. The method of claim 1 , wherein the sample comprises at least one selected from the group consisting of blood, serum, and plasma.

11. A method of analyzing nucleic acid, the method comprising:

protecting, in a population of nucleic acids, first and second ends of a target nucleic acid using a first Cas endonuclease and a second Cas endonuclease;

digesting unprotected nucleic acids with exonuclease while the target nucleic acid is protected by the first Cas endonuclease and a second Cas endonuclease; and

sequencing the target nucleic acid.

12. The method of claim 11 , wherein the population of nucleic acids is isolated from an organism and the target nucleic acid comprises a sequence foreign to a genome of the organism.

13. The method of claim 12 , wherein the target nucleic acid is from a genome of a pathogen of the organism.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2023
From: GENETICS RESEARCH, LLC, D/B/A ZS GENETICS, INC.
To: HARBINGER HEALTH, INC.
Reel/Frame 065568/0557 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2018
From: SHUBER, ANTHONY P.; GLOVER, WILLIAM; MEYERS, THOMAS C.
To: GENETICS RESEARCH, LLC, D/B/A ZS GENETICS, INC.
Reel/Frame 047633/0579 →
Continuity (5)
Continuation 15877620 · Jan 23, 2018
Provisional Application 62568144 · Oct 4, 2017
Provisional Application 62526091 · Jun 28, 2017
Provisional Application 62519051 · Jun 13, 2017
Related Publication 20190024143A1 · Jan 24, 2019
Cited By (1)
US 12,410,469